7MM Cancer Cachexia Market Poised for 8.9% CAGR Growth by 2034

Due to the implementation of innovative treatments.

The cancer cachexia market across seven major markets The (7MM) is projected to grow at a compound annual rate of 8.9% up to 2034, according to DelveInsight.

The expansion of this field is fueled by the development of innovative treatments, combined with an increase in disease occurrence, higher rates of aggressive tumor forms, and greater recognition in diagnosis.

A complex condition known as cancer cachexia, which occurs during later phases of cancer, involves a gradual loss of both skeletal muscle and body fat.

"Researchers are exploring various therapeutic options for managing cancer cachexia, and it is reasonable to expect that advancements in treatment will have a substantial effect on the cancer cachexia market throughout the projected timeframe," the report stated.

Seven major markets include the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.